May 26, 2017 10:49 PM ET

Biotechnology

Company Overview of Eleven Biotherapeutics, Inc.

Key Executives for Eleven Biotherapeutics, Inc.

NameBoard RelationshipsTitleAge
Stephen A. Hurly 14 RelationshipsChief Executive Officer, President and Director48
Reza Dana M.D., MPH,M.Sc14 RelationshipsFounder and Member of Scientific Advisory Board--
K. Christopher Garcia Ph.D.29 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Gregory L. Verdine Ph.D.46 RelationshipsCo-Founder57
Casey T. Weaver M.D.14 RelationshipsCo-Founder and Member of Scientific Advisory Board--
View More Key Executives

Eleven Biotherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Wendy L. Dixon Ph.D. 72 RelationshipsEleven Biotherapeutics, Inc.61
Stephen A. Hurly 14 RelationshipsEleven Biotherapeutics, Inc.48
K. Christopher Garcia Ph.D. 29 RelationshipsEleven Biotherapeutics, Inc.--
Karl Dane Wittrup Ph.D. 42 RelationshipsEleven Biotherapeutics, Inc.--
Reza Dana M.D., MPH,M.Sc 14 RelationshipsEleven Biotherapeutics, Inc.--
View All Board Members

Eleven Biotherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jane Pritchett V. Henderson14 Relationships3 Executives
Compensation Committee Ph.D.Wendy L. Dixon72 Relationships3 Executives
Nominating Committee M.B.A.Daniel S. Lynch80 Relationships3 Executives
Corporate Governance Committee M.B.A.Daniel S. Lynch80 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$119.1K
119.1K
393.8K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$119.1K
119.1K
19.1M
Compensation as of Fiscal Year 2016
Eleven Biotherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Merrimack Announces Management Change
May 25, 2017 8:30 PM ET
Concert Pharmaceuticals, Inc. Announces Executive Changes
May 25, 2017 8:25 PM ET
Mirna Therapeutics, Inc. Announces the Resignation of Vincent O'Neill as Chief Medical Officer
May 25, 2017 8:08 PM ET
Bone Biologics Corporation Announces Resignation of William Coffin as Director
May 25, 2017 5:34 PM ET
Akebia Therapeutics Appoints Rita Jain as Chief Medical Officer
May 25, 2017 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eleven Biotherapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.